AKR1B1 and neoplasm: Aldo-keto reductase 1 member B1 (AKR1B1) that drives glucose flux through the polyol pathway, is also highly expressed in ACC and may play a critical role in tumor development and progression through carbonyl detoxification, retinoic acid homeostatic regulation, and lipid metabolic control [20].